Clinical trialNATerminated
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers
A Randomized, Controlled Trial Examining the Use of The "Serious Illness Conversation Guide" (SICG) in Patients With Advanced Gastro-Intestinal Cancers
- Outcome
- Stopped earlyCovid-19 (Other)
- Phase
- NA
- Status
- Terminated
- Study type
- Interventional
- Start
- 16 September 2019
- Expected end
- 11 October 2020
- Enrollment
- 12 participants
- Sites
- 1
- Primary outcomes
- Difference in proportions of patients with documented goals of care
- Sponsor
- Other
- Results posted
- No
- Last update
- 27 January 2023
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The purpose of the study is to determine whether standardized implementation of a scripted template for discussing important issues that arise near the end of life improves the care of those who have advanced cancer.
Detailed description public domain (ClinicalTrials.gov)
Primary Objective: To determine whether the Serious Illness Conversation Guide will improve the consistency with which providers have and document conversations regarding patients' goals and priorities as they near the end of life. Secondary Objectives: 1. To assess whether having conversations as per this model will improve the quality of care near the end of life as determined by appropriate care in concordance with their goals of care. 2\. To assess whether having conversations as per this model will improve patient Quality of Life (QOL) as per a validated scale. 3\. To assess in patients with concordant care whether this model will improve patient QOL as per a validated scale 4. To assess provider opinions about end-of-life conversations.